United States - English - NLM (National Library of Medicine)

cvs pharmacy - nicotine (unii: 6m3c89zy6r) (nicotine - unii:6m3c89zy6r) - nicotine 4 mg - stop smoking aid

United States - English - NLM (National Library of Medicine)

target corporation - nicotine (unii: 6m3c89zy6r) (nicotine - unii:6m3c89zy6r) - nicotine 2 mg - stop smoking aid

Australia - English - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - nicotine polacrilex, quantity: 26.66 mg (equivalent: nicotine, qty 4 mg) - tablet, uncoated - excipient ingredients: mannitol; sodium carbonate; aspartame; potassium bicarbonate; sodium alginate; xanthan gum; magnesium stearate; flavour - relief of nicotine withdrawal symptoms including cravings associated with smoking cessation. nicotine lozenges may also be used as part of a smoking reduction strategy by smokers who are unable or not ready to stop smoking abruptly as a step towards stopping smoking. if possible, when stopping smoking, should be used in conjunction with behavioural support program.

Australia - English - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - nicotine polacrilex, quantity: 13.33 mg (equivalent: nicotine, qty 2 mg) - tablet, uncoated - excipient ingredients: mannitol; potassium bicarbonate; aspartame; sodium alginate; sodium carbonate; magnesium stearate; xanthan gum; flavour - relief of nicotine withdrawal symptoms including cravings associated with smoking cessation. nicotine lozenges may also be used as part of a smoking reduction strategy by smokers who are unable or not ready to stop smoking abruptly as a step towards stopping smoking. if possible, when stopping smoking, should be used in conjunction with behavioural support program.

Australia - English - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - nicotine polacrilex, quantity: 26.66 mg (equivalent: nicotine, qty 4 mg) - tablet, uncoated - excipient ingredients: aspartame; sodium alginate; xanthan gum; potassium bicarbonate; magnesium stearate; sodium carbonate; mannitol; flavour - relief of nicotine withdrawal symptoms including cravings associated with smoking cessation. nicotine lozenges may also be used as part of a smoking reduction strategy by smokers who are unable or not ready to stop smoking abruptly as a step towards stopping smoking. if possible, when stopping smoking, should be used in conjunction with behavioural support program.

Australia - English - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - nicotine polacrilex, quantity: 13.33 mg (equivalent: nicotine, qty 2 mg) - tablet, uncoated - excipient ingredients: aspartame; xanthan gum; mannitol; sodium alginate; sodium carbonate; magnesium stearate; potassium bicarbonate; flavour - relief of nicotine withdrawal symptoms including cravings associated with smoking cessation. nicotine lozenges may also be used as part of a smoking reduction strategy by smokers who are unable or not ready to stop smoking abruptly as a step towards stopping smoking. if possible, when stopping smoking, should be used in conjunction with behavioural support program.

Australia - English - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - nicotine polacrilex, quantity: 26.66 mg (equivalent: nicotine, qty 4 mg) - tablet, uncoated - excipient ingredients: sodium alginate; potassium bicarbonate; magnesium stearate; sodium carbonate; mannitol; xanthan gum; aspartame; flavour - relief of nicotine withdrawal symptoms including cravings associated with smoking cessation. nicotine lozenges may also be used as part of a smoking reduction strategy by smokers who are unable or not ready to stop smoking abruptly as a step towards stopping smoking. if possible, when stopping smoking, should be used in conjunction with behavioural support program.

Australia - English - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - nicotine polacrilex, quantity: 13.33 mg (equivalent: nicotine, qty 2 mg) - tablet, uncoated - excipient ingredients: mannitol; sodium carbonate; xanthan gum; potassium bicarbonate; sodium alginate; magnesium stearate; aspartame; flavour - relief of nicotine withdrawal symptoms including cravings associated with smoking cessation. nicotine lozenges may also be used as part of a smoking reduction strategy by smokers who are unable or not ready to stop smoking abruptly as a step towards stopping smoking. if possible, when stopping smoking, should be used in conjunction with behavioural support program.

United States - English - NLM (National Library of Medicine)

american sales company - nicotine (unii: 6m3c89zy6r) (nicotine - unii:6m3c89zy6r) - nicotine 4 mg - stop smoking aid

United States - English - NLM (National Library of Medicine)

strategic sourcing services llc - nicotine (unii: 6m3c89zy6r) (nicotine - unii:6m3c89zy6r) - nicotine 2 mg - stop smoking aid